The fields both of cancer prevention and epigenetics have matured to a point where their intersection deserves sustained attention. There now is strong evidence for an epigenetic component of early neoplasia, and data on the cancer preventive properties of epigenetic modulation are emerging. With
No takes yet. Share an insight, caveat, or question.
Jean‐Pierre J. Issa (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: